Chemical Nametecovirimat
Dosage FormCapsule (oral; 200 mg)
Drug ClassAntivirals
SystemSkin, Blood, Respiratory
CompanySiga Technologies
Approval Year2018


  • TPOXX is indicated for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.
Last updated on 10/19/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
TPOXX (tecovirimat) Prescribing Information2018Siga Technologies